Identification of Immune Subtypes for Predicting the Prognosis of Patients in Head and Neck Squamous Cell Carcinoma
Head and neck squamous cell carcinoma (HNSCC) is a common malignancy with poor prognosis and immune response, which plays an important role in tumor progression. Recently, immunotherapies have revolutionized the therapeutic means of malignancies including HNSCC. However, the relationship between imm...
Main Authors: | Jing Sun PhD, Guiqing Fang PhD, Zhibin Zuo PhD, Xijiao Yu PhD, Lande Xue PhD, Chong Li PhD, Shu Li PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-10-01
|
Series: | Technology in Cancer Research & Treatment |
Online Access: | https://doi.org/10.1177/15330338211045823 |
Similar Items
-
TP53-Associated Ion Channel Genes Serve as Prognostic Predictor and Therapeutic Targets in Head and Neck Squamous Cell Carcinoma
by: Jing Sun PhD, et al.
Published: (2020-11-01) -
RETRACTED: Efficacy and Safety of Cetuximab Plus Cisplatin Alone or in Combination With Paclitaxel in Patients With Head and Neck Squamous Cell Carcinoma: A Randomized Trial
by: Yanqing Zheng PhD, et al.
Published: (2021-05-01) -
Identifying KRT20 as a Potential Key Gene in Lymphatic Metastasis of Head and Neck Squamous Cell Carcinoma
by: Yi-Fan Zhang PhD, MD, et al.
Published: (2022-07-01) -
Patterns of Failure in Patients With Head and Neck Squamous Cell Carcinomas of Unknown Primary Treated With Chemoradiotherapy
by: Fatma Dhouib MD, et al.
Published: (2020-06-01) -
Fibroblasts in Head and Neck Squamous Cell Carcinoma Associated With
Perineural Invasion Have High-Level Nuclear Yes-Associated Protein (YAP)
Expression
by: Yanghua Wang MD, PhD, et al.
Published: (2015-11-01)